Happy New Year!

FDA Approves Pfizer Drug for Diabetes?
Wow - I read the headline and thought, "That's interesting, since I hadn't heard of a new diabetes drug coming." Turns out, the story was for Pfizer's pain medication Lyrica, which is used for diabetic neuropathy, not diabetes.

What a terrible, misleading headline - doesn't anyone edit this stuff?

GruntDoc strikes a nerve

I'm one of ABC News' People of the Year
(via Instapundit)

The uninsured was one of the "hot stories of 2004", and its not likely to improve in 2005

Update on the dueling malpractice initiatives in Washington state
Last month, the lawyer-supported initiative was submitted. This week, the physicians submitted their opposing initiative. The battle will be decided in the fall.

A lawyer weighs in on the malpractice debate
"Medical malpractice is not a contest between doctors and lawyers. It is instead an example of our legal system seeking to render justice through the time-honored tradition of the jury trial, and opposition to this system by insurance companies."

The Washington Post on the malpractice showdown in Maryland
"The medical malpractice special session in Annapolis seemed destined from the outset to end in a veto-override showdown -- and so it has."

CBS predicts the medical advancements for 2005

Many of the donated organs in China come from executed prisoners
Also of note, the number of executions in China exceeds by at least two fold the total number of executions in the rest of the world combined.

Colonoscopy still the best when compared to virtual colonoscopy
It's not even close - virtual colonoscopy is still not ready for prime time:

When analysed on a per-patient basis, for lesions 10 mm or larger in size (n=63), the sensitivity of ACBE was 48% (95% CI 35-61), CTC 59% (46-71, p=0·1083 for CTC vs ACBE), and colonoscopy 98% (91-100, p<0·0001 for colonoscopy vs CTC). For lesions 6-9 mm in size ...

Read more...



Pfizer is getting single-dose Azithromycin ready for battle
They recently submitted a trio of studies to the FDA, aiming for indications in acute bronchitis, sinusitis, and pneumonia. The obvious benefit of increased compliance is cited:

“"Single treatment is a major advance,"” commented Victor L. Yu, M.D., chief of infectious diseases at the Veterans Affairs Medical Center, Pittsburgh. "“In the real world, compliance is an issue.”"

"“Given the efficacy ...

Read more...

The governor of Maryland is likely to veto a malpractice reform bill
You can't please everyone all of the time - no bill is going to be perfect.

The malpractice insurance industry in Mississippi is being accused of racism

The FDA docs strike back against Dr. Topol
"'Dr. Topol shows a lack of understanding of the FDA's regulatory authority,' FDA doctors Lourdes Villalba and James Witter wrote in their letter."

One of my colleagues is in Thailand, and people are starting to get worried
Here's to a safe return Bill.

New Celebrex prescriptions fall 56 percent, Naproxyn 33 percent
It seems like people are being switched over to Mobic.

Following up yesterday's story on the lawsuit against Children's Advil, the attorney for the plaintiff states:

This is the equivalent of a medical tsunami -- there was no warning put out whatsoever on this apparently benign, over-the-counter medicine.
Just a bit over-the-top, don't you think? Clearly a statement from someone who is blinded by the dollar signs of lawsuits.

Medpundit puts him in his place:
I'm not sure ...

Read more...

In the aftermath of Vioxx, evidence-based medicine is more important than ever
At the end of this article, there is a nice section on Lodine, which was discussed here several times:

In undertaking its drug review, Veterans Affairs also re-examined the value of a lesser-known pain reliever, etodolac, and began using it more. The drug was first sold in 1991 as Lodine by a company that is now ...

Read more...

Vioxx tops porn as the top spam topic
Merck should be proud.

Most Popular